...
首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >G protein-coupled receptors in major psychiatric disorders
【24h】

G protein-coupled receptors in major psychiatric disorders

机译:严重精神疾病中的G蛋白偶联受体

获取原文
获取原文并翻译 | 示例

摘要

Although the molecular mechanisms underlying psychiatric illnesses such as depression, bipolar disorder and schizophrenia remain incompletely understood, there is increasing clinical, pharmacologic, and genetic evidence that G protein-coupled receptors (GPCRs) play critical roles in these disorders and their treatments. This perspectives paper reviews and synthesizes the available data. Dysfunction of multiple neurotransmitter and neuropeptide GPCRs in frontal cortex and limbic-related regions, such as the hippocampus, hypothalamus and brainstem, likely underlies the complex clinical picture that includes cognitive, perceptual, affective and motoric symptoms. The future development of novel agents targeting GPCR signaling cascades remains an exciting prospect for patients refractory to existing therapeutics. (c) 2006 Elsevier B.V. All rights reserved.
机译:尽管仍未完全了解诸如抑郁症,躁郁症和精神分裂症等精神疾病的分子机制,但越来越多的临床,药理学和遗传学证据表明,G蛋白偶联受体(GPCR)在这些疾病及其治疗中起着关键作用。本文从前瞻性的角度审查并综合了可用数据。额叶皮质和与边缘相关的区域(例如海马,下丘脑和脑干)中的多种神经递质和神经肽GPCR功能异常,可能是复杂的临床表现的基础,包括认知,知觉,情感和运动症状。靶向GPCR信号级联反应的新型药物的未来发展对于难治性现有疗法的患者而言仍然是令人兴奋的前景。 (c)2006 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号